Path: utzoo!attcan!uunet!know!zaphod.mps.ohio-state.edu!swrinde!ucsd!orion.oac.uci.edu!ucivax!ucla-cs!Fisk@f462.n204.z1.fidonet.org
From: Fisk@f462.n204.z1.fidonet.org (Fisk)
Newsgroups: sci.med.aids
Subject: SALK
Message-ID: <40187@shemp.CS.UCLA.EDU>
Date: 16 Oct 90 13:58:21 GMT
Sender: news@CS.UCLA.EDU
Organization: FidoNet node 1:204/462 - HTG/Outreach, San Mateo CA
Lines: 9
Approved: phil@wubios.wustl.edu
Note:	Copyright 1990 by Daniel R. Greening.  Permission granted for
Note:	non-commercial reproduction.
Archive-number: 2631

Does anyone know anything about the Salk HIV Immunogen, there is a trial going 
at U. C. Med.? Also,does anyone know anything about HIV GP 160 Antigen on 
trial at Stanford???  both are recruting HIV infected, with high T cell levels 
(above 600). Sounds interesting, but can not fine any info. in other bases. 
Ever been in a phase one or two trial???

--  
Uucp: ...{gatech,ames,rutgers}!ncar!asuvax!stjhmc!204!462!Fisk
Internet: Fisk@f462.n204.z1.fidonet.org